---
title: "Livzon Pharmaceutical Outlines Board and Committee Structure"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/280328605.md"
description: "Livzon Pharmaceutical Outlines Board and Committee Structure"
datetime: "2026-03-24T13:41:07.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/280328605.md)
  - [en](https://longbridge.com/en/news/280328605.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/280328605.md)
generator: "portal-rs"
---

# Livzon Pharmaceutical Outlines Board and Committee Structure

Livzon Pharmaceutical Outlines Board and Committee Structure

### Related Stocks

- [520690.CN](https://longbridge.com/en/quote/520690.CN.md)
- [159506.CN](https://longbridge.com/en/quote/159506.CN.md)
- [510660.CN](https://longbridge.com/en/quote/510660.CN.md)
- [000513.CN](https://longbridge.com/en/quote/000513.CN.md)
- [512010.CN](https://longbridge.com/en/quote/512010.CN.md)
- [159316.CN](https://longbridge.com/en/quote/159316.CN.md)
- [588130.CN](https://longbridge.com/en/quote/588130.CN.md)
- [562050.CN](https://longbridge.com/en/quote/562050.CN.md)
- [520880.CN](https://longbridge.com/en/quote/520880.CN.md)
- [512290.CN](https://longbridge.com/en/quote/512290.CN.md)
- [159992.CN](https://longbridge.com/en/quote/159992.CN.md)
- [159570.CN](https://longbridge.com/en/quote/159570.CN.md)
- [01513.HK](https://longbridge.com/en/quote/01513.HK.md)

## Related News & Research

- [Livzon Pharma buys 3.5% Xinbeijiang Pharma stake for RMB 106.7 million](https://longbridge.com/en/news/296601614.md)
- [Livzon Pharma FY26 H1 net profit drops 27.23% to RMB 932.2 million; revenue falls 20.28% to RMB 5 billion](https://longbridge.com/en/news/296600877.md)
- [Livzon Pharmaceutical’s First-Quarter Profit Slips as Policy Shift and Seasonality Hit Revenue](https://longbridge.com/en/news/283852429.md)
- [China's 1H25 Innovative Drug Out-Licensing Deal Value Exceeds USD100 Billion, Hitting New High](https://longbridge.com/en/news/293168428.md)
- [Asymchem Q1 2026 Revenue Rises but Profit Edges Lower](https://longbridge.com/en/news/284223624.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**